Muscle Mitochondrial Function in Patients with Type 2 Diabetes Mellitus and Peripheral Arterial Disease: Implications in Vascular Surgery

European Journal of Vascular and Endovascular Surgery

Volumn 38, Issue 3, 2009, Pages 356-364

  Pedersen, B L ^a   Baekgaard N ^a   Quistorff, B ^b  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Clinical outcome; Diabetes type 2; Mitochondrial function; Muscle energy metabolism; Peripheral bypass surgery

Indexed keywords

PHOSPHORUS;

ANGIOPLASTY; ARTERY DISEASE; BYPASS SURGERY; CLINICAL STUDY; GRAFT PATENCY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIMB ISCHEMIA; LITERATURE; MEDLINE; MUSCLE BIOPSY; MUSCLE FUNCTION; MUSCLE MITOCHONDRION; NEAR INFRARED SPECTROSCOPY; NON INSULIN DEPENDENT DIABETES MELLITUS; NON INVASIVE PROCEDURE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROGNOSIS; RESPIROMETRY; REVIEW; STANDARD; TREATMENT INDICATION; VASCULAR SURGERY;

BIOLOGICAL MARKERS; BIOPSY; CELL RESPIRATION; CHRONIC DISEASE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; HUMANS; ISCHEMIA; MAGNETIC RESONANCE SPECTROSCOPY; MITOCHONDRIA, MUSCLE; MUSCLE, SKELETAL; OXYGEN CONSUMPTION; PERIPHERAL VASCULAR DISEASES; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SEVERITY OF ILLNESS INDEX; SPECTROSCOPY, NEAR-INFRARED; VASCULAR SURGICAL PROCEDURES;

EID: 68249121088     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2009.04.014     Document Type: Review

References (53)

1. Bowtell J.L., Marwood S., Bruce M., Constantin-Teodosiu D., and Greenhaff P.L. Tricarboxylic acid cycle intermediate pool size: functional importance for oxidative metabolism in exercising human skeletal muscle. Sports Med 37 12 (2007) 1071-1088
2. McCully K.K., Mancini D., and Levine S. Nuclear magnetic resonance spectroscopy - its role in providing valuable insight into diverse clinical problems. Chest 116 (1999) 1434-1441
3. Quistorff B., Johansen L., and Sahlin K. Absence of phosphocreatine resynthesis in human calf muscle during ischaemic recovery. Biochem J 291 (1993) 681-686
4. Ratkevicius A., and Quistorff B. Metabolic cost of force generation for constant-frequency and catchlike-inducing electrical stimulation in human tibialis anterior muscle. Muscle Nerve 25 (2002) 419-426
5. 31Phosphorus magnetic resonance spectroscopy to evaluate medical therapy efficacy in peripheral arterial disease. Panminerva Med 41 (1999) 283-290
6. Greiner A., Esterhammer R., Messner H., Biebl M., Muhlthaler H., Fraedrich G., et al. High-energy phosphate metabolism during incremental calf exercise in patients with unilaterally symptomatic peripheral arterial disease measured by phosphor 31 magnetic resonance spectroscopy. J Vasc Surg 43 5 (2006) 978-986
7. 31P magnetic resonance spectroscopy. Clin Sci 71 (1986) 283-290
8. Keller U., Oberhänsli R., Huber P., Widmer L.K., Aue W.P., Hassink R.I., et al. Phosphocreatine content and intracellular pH of calf muscle measured by phosphorus NMR spectroscopy in occlusive arterial disease of the legs. Eur J Clin Invest 15 (1985) 382-388
9. 31P magnetic resonance spectroscopy. Clin Sci 89 (1995) 581-591
10. 31P magnetic resonance spectroscopy and near infrared spectroscopy study in vivo. J Vasc Surg 34 6 (2001) 1103-1110
11. Pipinos I.I., Shepard A.D., Anagnostopoulos P.V., Katsamouris A., and Boska M.D. Phosphorus 31 nuclear magnetic resonance spectroscopy suggests a mitochondrial defect in claudicating skeletal muscle. J Vasc Surg 31 (2000) 944-952
12. Schunk K., Romaneehsen B., Mildenberger P., Kersjes W., Schadmand-Fischer S., and Thelen M. Dynamic phosphorus-31 magnetic resonance spectroscopy in arterial occlusive disease - correlation with clinical and angiographic findings and comparison with healthy volunteers. Invest Radiol 32 11 (1997) 651-659
13. Schunk K., Romaneehsen B., Rieker O., Düber C., Kersjes W., Schadmand-Fischer S., et al. Dynamic phosphorus-31 magnetic resonance spectroscopy in arterial occlusive disease - effects of vascular therapy on spectroscopic results. Invest Radiol 6 (1998) 329-335
14. 31P-MR spectroscopy of the calf muscles in arterial occlusive disease. Fortschr Röntgenstr 156 4 (1992) 346-352
15. Wahl D.G., Simon J.-P., Robin B., Walker P., Jounny P., Escanye J.-M., et al. Phosphorus magnetic resonance spectroscopy: a non-invasive technique for the study of occlusive arterial leg disease and peripheral vasodilator therapy. Angiology 45 (1994) 367-376
16. Van der Grond J., Crolla R.M.P.H., Hove W.T., Van Vroonhoven T.J.M.V., and Mali W.P.T.h.M. Phosporus magnetic resonance spectroscopy of the calf muscle in patients with peripheral arterial occlusive disease. Invest Radiol 28 (1993) 104-108
17. Hands L.J., Payne G.S., Bore P.J., Morris P.J., and Radda G.K. Magnetic resonance spectroscopy in ischaemic feet. Lancet 2 (1986) 1391
18. 31P magnetic resonance spectroscopy. Eur J Vasc Surg 4 (1990) 637-642
19. 31P magnetic resonance spectroscopy: non-invasive biochemical analysis of the ischemic extremity. J Vasc Surg 3 3 (1986) 411-420
20. Bauer T.A., Brass E.P., and Hiatt W.R. Impaired muscle oxygen use at onset of exercise in peripheral arterial disease. J Vasc Surg 40 (2004) 488-493
21. 2): a new measure of symptomatic lower-extremity arterial disease. J Vasc Surg 38 4 (2003) 724-729
22. Egun A., Farooq V., Torella F., Cowley R., Thorniley M.S., and McCollum C.N. The severity of muscle ischemia during intermittent claudication. J Vasc Surg 36 (2002) 89-93
23. Komiyama T., Shigematsu, Yasuhara H., and Muto T. Near-infrared spectroscopy grades the severity of intermittent claudication in diabetics more accurately than ankle pressure measurement. British J Surg 87 (2000) 459-466
24. Kooijman M.H., Hopman M.T.E., Colier W.N.J.M., Van der Vliet A.J., and Oeseburg B. Near infrared spectroscopy for non-invasive assessment of claudication. J Surg Research 72 (1997) 1-7
25. McCully K.K., Halber C., and Posner J.D. Exercise-induced changes in oxygen saturation in the calf muscles of elderly subjects with peripheral vascular disease. J Gerontol Biol Sci 49 3 (1994) 128-134
26. Mohler E.R., Gwen L., Supple G.E., Wang H., and Chance B. Impaired exercise-induced blood volume in type 2 diabetes with or without peripheral arterial disease measured by continuous-wave near-infrared spectroscopy. Diabetes Care 29 (2006) 1856-1859
27. Tsuchiba H., Shigematsu H., Ishimaru S., Iwai T., Akaba N., and Umezu S. Effect of low-density lipoprotein apheresis on patients with peripheral arterial disease. Peripheral arterial disease LDL apheresis multicenter study (P-Las). Int Ang 25 (2006) 287-292
28. Ubbink D.T., and Koopman B. Near-infrared spectroscopy in the routine diagnostic work-up of patients with leg ischaemia. Eur J Vasc Endovasc Surg 31 (2006) 394-400
29. Watanabe T., Matsushita M., Nishikimi N., Sakurai T., Komori K., and Nimura Y. Near-infrared spectroscopy with treadmill exercise to assess lower limb ischemia in patients with atherosclerotic occlusive disease. Surg Today 34 (2004) 849-854
30. Eiberg J.P., Schroeder T.V., Vogt K.C., and Secher N.H. Near-infrared spectroscopy during peripheral vascular surgery. Cardiovasc Surg 5 3 (1997) 304-308
31. Eiberg J.P., Schroeder T.V., and Secher N.H. Improved postischemic recovery after peripheral bypass surgery assessed by near-infrared spectroscopy. Vasc Endovasc Surg 32 4 (1998) 361-366
32. Pipinos I.I., Judge A.R., Zhu Z., Selsby J.T., Swanson S.A., Johanning J.M., et al. Mitochondrial defects and oxidative damage in patients with peripheral arterial disease. Free Radic Biol Med 41 (2006) 262-269
33. Pipinos I.I., Sharov V.G., Shepard A.D., Anagnostopoulos P.V., Katsamouris A., Todor A., et al. Abnormal mitochondrial respiration in skeletal muscle in patients with peripheral arterial disease. J Vasc Surg 38 (2003) 827-832
34. Saks V.A., Veksler V.I., Kuznetsov A.V., Kay L., Sikk P., Tiivel T., et al. Permeabilized cell and skinned fiber techniques in studies of mitochondrial function in vivo. Mol Cell Biochem 184 (1998) 81-100
35. Thomas C., Sirvent P., Perrey S., Raynaud E., and Mercier J. Relationships between maximal muscle oxidative capacity and blood lactate removal after supramaximal exercise and fatigue indexes in humans. J Appl Physiol 97 (2004) 2132-2138
36. Norgren L., Hiatt W.R., Dormandy J.A., Nehler M.R., Harris K.A., Fowkes F.G.R., et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). Eur J Vasc Endovasc Surg 33 Suppl. 1 (2007) s1-s75
37. Makitie J., and Teravainen H. Histochemical changes in striated muscle in patients with intermittent claudication. Arch Pathol Lab Med 101 (1977) 658-663
38. Taylor S.M., Kalbaugh C.A., Blackhurst D.W., Cass A.L., Trent A., Langan E.M., et al. Determinants of functional outcome after revascularization for critical limb ischemia: an analysis of 1000 consecutive vascular interventions. J Vasc Surg 44 (2006) 747-756
39. Jensen L.P., Schroeder T.V., and Lorentzen J.E. In situ bypass and diabetes. Ugeskr laeger 155 39 (1993) 3115-3118
40. Söderström M., Arvela E., Albäck A., Aho P.-S., and Lepäntalo M. Healing of ischaemic tissue lesions after infrainguinal bypass surgery for critical leg ischaemia. Eur J Vasc Endovasc Surg (2008) 10.1016/j.ejvs.2008.01.027
41. Sun Z., Liu L., Liu N., and Liu Y. Muscular response and adaptation to diabetes mellitus. Front Biosci (2008 May) 4765-4794
42. Dolan N.C., Liu K., Criqui M.H., Greenland P., Guralnik J.M., Chan C., et al. Peripheral arterial disease, diabetes, and reduced lower extremity functioning. Diabetes Care 25 (2002) 113-120
43. Said G. Diabetic neuropathy - a review. Nat Clin Pract (Neurol) 3 6 (2007) 331-340
44. Oberbach A., Bossenz Y., Lehmann S., Niebauer J., Adams V., Paschke R., et al. Altered fiber distribution and fiber-specific glycolytic and oxidative enzyme activity in skeletal muscle of patients with type 2 diabetes. Diabetes Care 29 (2006) 895-900
45. Rabøl R., Højberg P.M.V., Almdal, Boushel R., Haugaard S.B., Madsbad S., et al. Effect of hyperglycemia on mitochondrial respiration in type 2 diabetes. J Clin Endocrin Metab (2009) 10.1210/jc.2008-1475 E-pub ahead of print
46. 31P MR spectroscopy and in vitro markers of oxidative capacity in type 2 diabetes patients. Magn Reson Mater Phy 19 6 (2006) 321-331
47. Klueber K.M., Feczko J.D., Schmidt G., and Watkins III J.B. Skeletal muscle in the diabetic mouse: histochemical and morphometric analysis. Anat Rec 225 1 (1989) 41-45
48. Secher N.H., Mizuno M., and Saltin B. Adaptation of skeletal muscles to training. Bull Eur Physiopathol Respir 20 (1984) 453-457
49. Creager M.A., Lüscher T.F., Cosentino F., and Beckman J.A. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. Circ 108 (2003) 1527-1532
50. Galaria I.I., Surowiec S.M., Tanski W.J., Fegley A.J., Rhodes J.M., Illig K.A., et al. Popliteal-to-distal bypass: identifying risk factors associated with limb loss and graft failure. Vasc Endovasc Surg 39 (2005) 393-400
51. Peyer H.C., Stirnemann, Dozzi M., and Althaus U. Factors determining the patency of femoropopliteal bypass grafts: an analysis of 350 procedures. Thorac Cardiovasc Surg 31 (1983) 163-168
52. Eckert P., and Schnackerz K. Ischemic tolerance of human skeletal muscle. Ann Plast Surg 26 (1991) 77-84
53. Steina R., Hriljaca I., Halperina J.L., Gustavsona S.M., Teodorescub V., and Olina J.W. Limitation of the resting ankle-brachial index in symptomatic patients with peripheral arterial disease. Vascular Medicine 11 (2006) 29-33